Evidence map›Paper›PMID 24777094›Full record

ArticleAntimicrobial agents and chemotherapy2014

Phasevarions mediate epigenetic regulation of antimicrobial susceptibility in Neisseria meningitidis.

Freda E-C Jen, Kate L Seib, Michael P Jennings

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Surviving Colonies ofAntibiotics (Basel, Switzerland) · 2025
    Article
  8. Single-Cell Microfluidics: A Primer for Microbiologists.The journal of physical chemistry. B · 2024
    Review
  9. Article
  10. Article
  11. Antimicrobial resistance and mechanisms of epigenetic regulation.Frontiers in cellular and infection microbiology · 2023
    Review
  12. Review
  13. Article
  14. Prokaryotic DNA methylation and its functional roles.Journal of microbiology (Seoul, Korea) · 2021
    Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Freda E-C JenInstitute for Glycomics, Griffith University, Southport, Queensland, Australia.
Kate L SeibInstitute for Glycomics, Griffith University, Southport, Queensland, Australia.
Michael P JenningsInstitute for Glycomics, Griffith University, Southport, Queensland, Australia m.jennings@griffith.edu.au.
Griffith University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phase variation is a common feature of host-adapted bacterial pathogens such as Neisseria meningitidis. Recently, we reported that this rapid on/off switching of gene expression occurs in DNA methyltransferases, altering expression in multiple genes via changes in global methylation. In the current study, we compared MIC values of strains with ModA11, ModA12, and ModD1 phasevarions, revealing MIC differences due to ModA11 and ModA12 switching, with a ModA11_OFF strain showing 4-fold reduced susceptibilities to ceftazidime and ciprofloxacin.

Indexed as

Anti-Bacterial AgentsCeftazidimeCiprofloxacinDNA, BacterialDNA (Cytosine-5-)-MethyltransferasesDNA MethylationDrug Resistance, Multiple, BacterialEpigenesis, GeneticGene Expression Regulation, BacterialMicrobial Sensitivity TestsNeisseria meningitidisAnti-Bacterial AgentsCeftazidimeCiprofloxacinDNA, BacterialDNA (Cytosine-5-)-Methyltransferases

Identifiers

PMID24777094
PMCPMC4068601
OpenAlexW2168562077

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.